Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Get 'em while they're HOT
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, not yet licensed by the MHRA or EMA, and currently in Phase 2 and Phase 3 clinical trials
In studies, after 52 weeks, participants on the highest dose of Mounjaro (15 mg per week): Lowered their total cholesterol by about 5.6 percent Lowered their triglycerides by 22.5 percent Lowered their LDL (bad) cholesterol by 7.9 percent Lowered their VLDL cholesterol by 21.8 percent Increased their HDL (good) cholesterol by 10.8 percent Additionally, a meta-analysis (analysis of data from several clinical trials) from The Lancet found that Ozempic lowered cardiovascular risk and even decreased the risk of death in people with diabetes and heart disease
It does not make a vial immortal, and it does not reverse contamination, but it can reduce microbial growth risk compared with plain sterile water when a vial is accessed more than once
Factors such as eating habits, meal composition, and the rate of dose titration can significantly influence the severity of gastrointestinal side effects
US$ 21.49
US$ 27.75
US$ 24.72
US$ 21.07
US$ 25.41
